World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
60466
World Ranking
4303
National Ranking
20

Overview

Heinz Ludwig is affiliated with the University of Vienna in Austria and has a significant publication record primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research work spans several subfields, including Hematology, Molecular Biology, Oncology, Infectious Diseases, and Epidemiology.

Ludwig's scientific contributions focus on topics such as Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Cancer Treatment and Pharmacology, Peptidase Inhibition and Analysis, HIV/AIDS drug development and treatment, Cancer therapeutics and mechanisms, and Hepatitis B Virus Studies.

Key recent publications by Heinz Ludwig include:

  • "Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study" (2020) in The Lancet Haematology
  • "Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group" (2021) in The Lancet Oncology
  • "International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)" (2020) in Blood Cancer Journal
  • "Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment" (2020) in The Oncologist
  • "MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents" (2020) in Journal of Hematology & Oncology

Ludwig collaborates frequently with several researchers, including:

  • Pieter Sonneveld
  • Evangelos Terpos
  • María-Victoria Mateos
  • Niklas Zojer
  • Roman Hájek

The scientist often publishes in journals such as Blood, Clinical Lymphoma Myeloma & Leukemia, HemaSphere, Leukemia, and The Lancet Haematology. The distribution of Ludwig's publications shows notable engagement with Blood, one of the leading journals in hematology, with fifteen publications attributed.

Their data-driven research frequently addresses clinical challenges associated with multiple myeloma, as reflected in the range of papers and their broad focus spanning treatment protocols, risk stratification, and epidemiological correlations worldwide.

Best Publications

  • International staging system for multiple myeloma.

    Philip R. Greipp;Jesus San Miguel;Brian G.M. Durie;John J. Crowley

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie

  • Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

    Carsten Bokemeyer;Igor Bondarenko;Anatoly Makhson;Joerg T. Hartmann

  • Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    S. Vincent Rajkumar;Jean Luc Harousseau;Brian Durie;Kenneth C. Anderson

  • The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients

    Heinz Ludwig;Simon Van Belle;Peter Barrett-Lee;Gunnar Birgegård

  • Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    A. Palumbo;S. V. Rajkumar;M. A. Dimopoulos;P. G. Richardson

  • Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

    Meletios Athanasios Dimopoulos;Philippe Moreau;Antonio Palumbo;Douglas Edgar Joshua

  • International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel

  • Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

    R A Kyle;B G M Durie;S V Rajkumar;O Landgren

  • Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

    Lotfi Benboubker;Meletios Athanasios Dimopoulos;Angela Dispenzieri;John Catalano

  • Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    P. Moreau;J. San Miguel;P. Sonneveld;M. V. Mateos

  • Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

    Antonio Palumbo;Sara Bringhen;Maria Victoria Mateos;Alessandra Larocca

  • Erythropoietin treatment of anemia associated with multiple myeloma.

    Heinz Ludwig;Elke Fritz;Harald Kotzmann;Paul Höcker

  • Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.

    Brian G M Durie;Robert A. Kyle;Andrew Belch;William Bensinger

  • Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group

    Meletios A. Dimopoulos;Evangelos Terpos;Asher Chanan-Khan;Nelson Leung

  • Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3

    Meletios Dimopoulos;Robert Kyle;Jean Paul Fermand;S. Vincent Rajkumar

  • MDR1 Gene Expression and Treatment Outcome in Acute Myeloid Leukemia

    Robert Pirker;Josef Wallner;Klaus Geissler;Werner Linkesch

  • International Myeloma Workshop Consensus Panel 1. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    Sv Rajkumar;Jl Harousseau;B Durie;Kc Anderson

Frequent Co-Authors

Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Roman Hájek
Roman Hájek University of Ostrava
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Antonio Palumbo
Antonio Palumbo University of Turin
Michele Cavo
Michele Cavo University of Bologna
Hartmut Goldschmidt
Hartmut Goldschmidt University Hospital Heidelberg
Richard Greil
Richard Greil Paracelsus Medical University
Mario Boccadoro
Mario Boccadoro University of Turin
Thierry Facon
Thierry Facon Centre Hospitalier Régional et Universitaire de Lille
Hermann Einsele
Hermann Einsele University of Würzburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA often opens doors to a variety of related healthcare degrees and career paths. Many students start with an RN qualification and later advance their credentials. For those already holding an RN, choosing the cheapest rn to bsn program can be a cost-effective way to earn a Bachelor of Science in Nursing online.

Individuals with non-nursing backgrounds but aiming for a nursing career might explore the cheapest direct entry msn programs. These programs provide a pathway to advanced nursing roles and can be completed entirely online.

Admission requirements and program competitiveness can be a concern. Considering the easiest rn program to get into may help students balance their aspirations with acceptance odds.

For those interested in allied health careers, medical billing and coding is a fast-growing option. Checking out accredited medical billing and coding schools online with financial aid can lead to entry into the healthcare field with greater financial flexibility.

Best Scientists Citing Heinz Ludwig

Trending Scientists

Recently Published Articles